[Economic drug evaluation: experiences and pathways to progress]
Gac Sanit
.
2008 Jul-Aug;22(4):354-7.
doi: 10.1157/13125358.
[Article in Spanish]
Authors
José Antonio Sacristán
1
,
Tatiana Dilla
,
José Luis Pinto
,
Fernando Antoñanzas
Affiliation
1
Departamento de Investigación Clínica, Lilly S.A., Madrid, España. sacristan-jose@lilly.com
PMID:
18755087
DOI:
10.1157/13125358
No abstract available
MeSH terms
Costs and Cost Analysis
Pharmaceutical Preparations / economics*
Spain
Substances
Pharmaceutical Preparations